
RSA appoints Matt Ryans as its new finance director.
pharmafile | November 19, 2009 | Appointment | Business Services | appointment, business services, rsa
Global life sciences executive search and interim management specialist RSA has appointed Matt Ryans as its new finance director.
He previously served as RSA’s financial controller for over a year and in his new role, Matt will be responsible for long-term financial planning and will report directly to the chief exeuctive and management board. He will also oversee RSA’s global budgeting process and manage the company’s financial risk.
Matt said: “Having worked with RSA for over a year now I have gained first hand understanding of the quality differentiators that set the company apart from its competitors, as well as gaining insight into the company’s long-term goals. I am excited to take on this new level of responsibility and look forward to helping RSA continue to thrive as we emerge from this seemingly difficult economic period.”
Working across RSA’s global network, Matt comes to the role with over a decade of experience in the financial services sector, including managing the finances for a small biotech firm undertaking stage II clinical trials of a new cancer therapy while working full time as finance director for The Great Pie Shop.
Nick Stephens, chief executive of RSA, said: “We believe Matt is well positioned to succeed in this new role given his broad financial knowledge and experience in the life sciences sector. He is already a well respected member of the RSA team and we therefore feel very lucky that Matt is taking up this new position.”
Related Content

Astellas selects Veeva Vault CRM as global commercial platform
Astellas has selected Veeva Vault CRM as its global customer relationship management (CRM) platform, with …

David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.

Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …






